Idorsia's Fabry Drug Founders In Phase III

Lucerastat Fails To Reduce Neuropathic Pain

 
• By Kevin Grogan
Idorsia building
Setback for Swiss biotech • Source: Idorsia

More from Clinical Trials

More from R&D